You are here: » News


The German Research Foundation has approved a Collaborative Research Centre (CRC) at the University of Cologne

The new CRC 1607 ‘Immunomodulating and anti(lymph)angiogenic therapies for age-related eye diseases that can lead to blindness’ will receive funding from the German Research Foundation for the next three years and nine months. Professor Dr Claus Cursiefen, recently elected Vice-Rector for Research at the University of Cologne and Chairman of the Department of Opthalmology at the University Hospital Cologne, explains that the new CRC investigates how eye diseases that occur in old age develop and looks for novel treatments for these diseases.

Hendrik Scholl receives honorary doctorate from Semmelweis University

On 16.11.2023, Prof. Dr. Hendrik Scholl was awarded an honorary doctorate by Semmelweis University in Hungary

Helen Keller Prize for Vision Research 2024

Professor Cuhna-Vaz has been awarded with the Helen Keller Prize for Vision Research

Kupfer Award 2024

Hendrik Scholl, Director of IOB’s Clinical Center, has been selected to receive the 2024 Kupfer Award of the Association for Research in Vision and Ophthalmology (ARVO).

Clinical trial suggests pegcetacoplan may slow onset of age-related macular degeneration

An international team of researchers has found via clinical trial that the drug pegcetacoplan may slow the onset of age-related macular degeneration in some people.

Algorithm identifies early vascular disease using photos of the eye

Researchers at the University and the University Hospital of Bonn have developed a method that could be used to diagnose atherosclerosis. Using self-learning software, they were able to identify vascular changes in patients with peripheral arterial disease (PAD), often at an early stage.

Glaucoma: Seeing the light at the end of the tunne

Reduced blood flow and impaired neurovascular coupling are well-known features of glaucoma, the main cause of non-curable blindness affecting 80 million people worldwide in 2020. The mechanisms underlying these abnormalities are now unveiled, thanks to new research by a team led by Adriana Di Polo, professor of neuroscience and ophthalmology at Université de Montréal.

Implanted chip, natural eyesight coordinate vision in study of macular degeneration

Two years ago, a Stanford researcher and his team showed that with a thin, pixelated chip and specially designed glasses, they could restore limited vision in the center of the visual field of patients suffering from macular degeneration. In a recent, follow-up study, the researchers found that this prosthetic vision naturally integrated with the patients' peripheral vision, which was unaffected by the disease.

Open-access publishing fees deter researchers in the global south

Authors in low-income countries rarely published free-to-read papers, even when they qualified for publication-fee waivers.

Ocuphire Pharma completes enrollment in MIRA-3 Pivotal Phase 3 clinical trial for Nyxol in RM

The company completed enrollment ahead of schedule in a second Phase 3 FDA registration trial for Nyxol in RM with top-line results expected by the end of the first quarter.

Choroidal thickness reduced for individuals with migraine

Mahdi Gouravani, from the Tehran University of Medical Sciences in Iran, and colleagues conducted a meta-analysis to examine choroidal thickness measurements for individuals with migraine and healthy individuals.

Trials show promise for intravitreal faricimab in retinal disease

Faricimab is noninferior to aflibercept for the treatment of neovascular age-related macular degeneration (nAMD) and diabetic macular edema, according to two studies published in The Lancet.

Aqueous biomarkers may help predict treatment response in neovascular age-related macular degeneration

Aqueous biomarkers could help identify patients with neovascular age-related macular degeneration (nvAMD) who may not require, or who may not benefit from, long-term antivascular endothelial growth factor (VEGF) therapy.

eSight, Be My Eyes announce sweepstakes winner

The Toronto-based medical eyewear company partnered with the visual assistance community to help empower an Oregon college student with enhanced vision.